{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:45:39Z","timestamp":1790790339011,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"X&Y solutions Inc."},{"DOI":"10.13039\/501100009580","name":"Chinese PLA General Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009580","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Lab for Cardiovascular Precision Medicine"},{"name":"The National Key Research and Development Program of China"},{"name":"Beijing Municipal Science & Technology Commission"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.cca.2018.12.022","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T11:37:16Z","timestamp":1545219436000},"page":"63-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Syndecan-1 as an independent risk factor for the incidence of adverse cardiovascular events in patients having stage C and D heart failure with non-ischemic dilated cardiomyopathy"],"prefix":"10.1016","volume":"490","author":[{"given":"Wei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deli","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4930-5633","authenticated-orcid":false,"given":"Yan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.cca.2018.12.022_bb0005","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cca.2018.12.022_bb0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.116.027134","article-title":"Personalizing risk stratification for sudden death in dilated cardiomyopathy: the past, present, and future","volume":"136","author":"Halliday","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cca.2018.12.022_bb0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609758","article-title":"Declining risk of sudden death in heart failure","volume":"377","author":"Shen","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.cca.2018.12.022_bb0020","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"13","key":"10.1016\/j.cca.2018.12.022_bb0025","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jacc.2008.11.052","article-title":"Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate","volume":"53","author":"Bogun","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.cca.2018.12.022_bb0030","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2018.12.022_bb0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fphys.2017.00238","article-title":"Current understanding of the pathophysiology of myocardial fibrosis and its quantitative assessment in heart failure","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cca.2018.12.022_bb0040","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fphys.2016.00484","article-title":"Late gadolinium enhancement amount as an independent risk factor for the Incidence of adverse cardiovascular events in patients with stage C or D heart failure","volume":"7","author":"Liu","year":"2016","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.cca.2018.12.022_bb0045","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00441-016-2454-2","article-title":"Syndecans in heart fibrosis","volume":"365","author":"Lunde","year":"2016","journal-title":"Cell Tissue Res."},{"issue":"4","key":"10.1016\/j.cca.2018.12.022_bb0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/CIRCULATIONAHA.106.644609","article-title":"Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction","volume":"115","author":"Vanhoutte","year":"2007","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.cca.2018.12.022_bb0055","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1253\/circj.CJ-14-1195","article-title":"Syndecan-1 in acute decompensated heart failure\u2014association with renal function and mortality","volume":"79","author":"Neves","year":"2015","journal-title":"Circ. J."},{"issue":"3","key":"10.1016\/j.cca.2018.12.022_bb0060","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/CIRCHEARTFAILURE.113.000846","article-title":"Fibrosis marker syndecan-1 and outcome in patients with heart failure with reduced and preserved ejection fraction","volume":"7","author":"Tromp","year":"2014","journal-title":"Circ. Heart Fail."},{"issue":"5","key":"10.1016\/j.cca.2018.12.022_bb0065","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.cca.2018.12.022_bb0070","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.109.192064","volume":"119","author":"Jessup","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cca.2018.12.022_bb0075","first-page":"57","article-title":"Dilemmas in end-stage heart failure","volume":"12","author":"Chen-Scarabelli","year":"2015","journal-title":"J. Geriatr. Cardiol."},{"issue":"2","key":"10.1016\/j.cca.2018.12.022_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.109.137885","article-title":"Syndecan-1 amplifies angiotensin II-induced cardiac fibrosis","volume":"55","author":"Schellings","year":"2010","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.cca.2018.12.022_bb0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bph.14397","article-title":"Soluble syndecans: biomarkers for diseases and therapeutic options","volume":"176","author":"Bertrand","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.cca.2018.12.022_bb0090","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1074\/jbc.M807001200","article-title":"Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis","volume":"284","author":"Kliment","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cca.2018.12.022_bb0095","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cca.2018.12.022_bb0100","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCULATIONAHA.108.811547","article-title":"Cardiovascular magnetic resonance","volume":"121","author":"Pennell","year":"2010","journal-title":"Circulation"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118306521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118306521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T23:26:08Z","timestamp":1548285968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898118306521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":20,"alternative-id":["S0009898118306521"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2018.12.022","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndecan-1 as an independent risk factor for the incidence of adverse cardiovascular events in patients having stage C and D heart failure with non-ischemic dilated cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2018.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}